Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Whether GLP-1s are covered by insurance has huge implications nationally because the drugs, which were first approved to treat diabetes and later obesity, are also being studied for possible future treatment of a wide range of other conditions, from kidney disease to Alzheimers to substance abuse disorder, thus accelerating demand
Associations of GSTM1 and GSTT1 polymorphisms with pancreatic cancer risk: evidence from a meta-analysis
even with the inclusion of new small-sample studies, the conclusions remain robust
doi:10.1074/jbc.M209372200
2019;42(Suppl 1):S90102
US$ 27.48
US$ 20.55
US$ 27.91
US$ 25.10
US$ 21.95
